NameMonitoring and evaluation Sessions PDF version Wednesday, 23 October 10:00 e-poster session day 110:00 to 19:20Digital kioskse-poster session 11:50 Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research11:50 to 13:20Auditorium IMajor sessionLives at risk: mental health and substance use11:50 to 13:20Auditorium VIIOral presentation sessionPrevalence of opioids and related harms11:50 to 13:20Auditorium VIIIOral presentation sessionSupport for recovery11:50 to 13:20Room 1.07Short communication sessionEvaluation of drug consumption rooms: guidance step by step11:50 to 13:20Room 1.15Workshop 14:20 Neuroscience and cognition14:20 to 15:50Auditorium IIIShort communication sessionLegal shifts and their Impact on drug use and sentencing14:20 to 15:50Auditorium IVOral presentation sessionGender and substance use14:20 to 15:50Auditorium VIIIOral presentation sessionChallenge of measuring use and impact of cannabinoids14:20 to 15:50Room 1.07Oral presentation session 16:00 Measuring drug market phenomenon16:00 to 17:30Auditorium VIOral presentation sessionAssessment of behavioural addictions16:00 to 17:30Room 5BOral presentation sessionQuality in addictions work systems16:00 to 17:30Room 1.06Oral presentation sessionConceptualising health and harms16:00 to 17:30Room 1.08Short communication session 17:50 Strengthening quality in substance use disorders treatment17:50 to 19:20Auditorium IIOral presentation sessionNPS: trends, concerns and response strategies17:50 to 19:20Auditorium IIIOral presentation sessionDrug use trends17:50 to 19:20Auditorium IVOral presentation sessionDecriminalisation and alternatives to arrest17:50 to 19:20Auditorium VIOral presentation sessionPsychedelics 117:50 to 19:20Auditorium VIIIOral presentation sessionHepatitis C, HIV, and other drug related harms17:50 to 19:20Room 1.05Short communication sessionOpioids: trends, use and treatments17:50 to 19:20Room 1.06Short communication session Thursday, 24 October 10:00 Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.10:00 to 11:30Room 1.10WorkshopWorkshop on conducting drug research in prison: Challenges and key recommendations from the European experience10:00 to 11:30Room 1.15Workshop 11:50 Opioid Agonist Treatment: novel formulations and challenges11:50 to 13:20Auditorium IVOral presentation sessionEvidence informed drug and alcohol policy11:50 to 13:20Auditorium VIOral presentation sessionEmerging drug harms, DCRs and other responses11:50 to 13:20Auditorium VIIShort communication sessionInnovative methods for understanding drug markets and policy11:50 to 13:20Room 5AOral presentation sessionContemporary issues11:50 to 13:20Room 1.08Oral presentation session 14:20 Understanding harm reduction: economic, social, and health perspectives14:20 to 15:50Room 1.05Short communication sessionEuropean prevention curriculum: increasing the use of evidence-based prevention14:20 to 15:50Room 1.06Short communication session 16:00 NPS: Pharmacological Characterization and Substance Analysis16:00 to 17:30Auditorium IIIOral presentation sessionHepatitis C testing and treatment16:00 to 17:30Auditorium IVOral presentation sessionHow can treatment be a better experience?16:00 to 17:30Auditorium VIIOral presentation sessionCity insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction16:00 to 17:30Room 1.07WorkshopDrug trends: experiences from Brazil, the Netherlands, Portugal, and Spain16:00 to 17:30Room 1.08Oral presentation sessionHow to respond to real-time drug alerts in European countries ?16:00 to 17:30Room 1.15Workshop 17:50 Viral hepatitis among people who inject drugs17:50 to 19:20Auditorium IVOral presentation sessionHospital-based treatments17:50 to 19:20Room 5BOral presentation sessionFrom old to new: changes in drug use17:50 to 19:20Room 5COral presentation sessionNewly Regulated Markets, Managing Harms, Treatment & Advocating for Reform17:50 to 19:20Room 1.06Short communication sessionA two-phased augmentation/intervention extension of Claremont’s media-based prevention education model17:50 to 19:20Room 1.10Workshop Friday, 25 October 11:50 Alcohol: interventions and up-to-date technologies11:50 to 13:20Auditorium IIOral presentation sessionDrugs checking services11:50 to 13:20Room 5AOral presentation sessionOnline monitoring11:50 to 13:20Room 5BOral presentation sessionSubstance use and treatment needs across European prisons11:50 to 13:20Room 5COral presentation sessionEmerging challenges in drug markets: monitoring, measurement & impacts11:50 to 13:20Room 1.05Short communication sessionHow can cannabis policy goals inform the development of evaluation indicators?11:50 to 13:20Room 1.08Workshop 14:20 Addressing diverse treatment needs14:20 to 15:50Auditorium VIOral presentation sessionSubstance use and mental health in prison settings14:20 to 15:50Auditorium VIIOral presentation sessionRegulating cannabis supply policies in Europe: navigating the long road to change14:20 to 15:50Auditorium VIIIOral presentation sessionHolistic care for mental well-being14:20 to 15:50Room 1.05Short communication session 16:00 Novel psychoactive substances and latest drug trends in Asia and Pacific countries16:00 to 17:30Room 1.05Oral presentation session Presentations Wed 23 Oct 10:00 e-poster"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome 10:00 to 19:20 Digital kiosks Katarzyna Iwanickae-poster"Make the difference" - Qualifying professionals working with families with addiction issues 10:00 to 19:20 Digital kiosks Rebekka Kleinate-poster"Pictures (and Drugs) at an exibition" 10:00 to 19:20 Digital kiosks Patrizio Lamonacae-poster"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden 10:00 to 19:20 Digital kiosks Katja Troberge-poster30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment. 10:00 to 19:20 Digital kiosks Julian Vicentee-posterA business of supplying harm reduction : a necessary evil? 10:00 to 19:20 Digital kiosks François Destombee-posterA digital approach to peer led recovery and social connection to address substance use/and or mental health challenges 10:00 to 19:20 Digital kiosks Susan Barnese-posterA feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD) 10:00 to 19:20 Digital kiosks Laia Miquele-posterA Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal 10:00 to 19:20 Digital kiosks Hilson Cunha Filhoe-posterA narrative review of nurse-led addiction models of care; informing the foundations for international nursing. 10:00 to 19:20 Digital kiosks Sadie Lavelle Cafferkeye-posterA National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care 10:00 to 19:20 Digital kiosks Philippa Casee-posterA Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations 10:00 to 19:20 Digital kiosks Jo-Hanna Iverse-posterA systematic review of second-hand smoking mass media campaigns (2002-2022) 10:00 to 19:20 Digital kiosks Carmen Lime-posterActivities and Experiences of Czech Adolescents in Cyberspace 10:00 to 19:20 Digital kiosks Martin Dolejše-posterAcute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults 10:00 to 19:20 Digital kiosks Sorcha Hamiltone-posterAddiction, a volitional disorder. 10:00 to 19:20 Digital kiosks Nicolas Figueirede-posterAddiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction 10:00 to 19:20 Digital kiosks Shawn Rutledgee-posterAddictive Behaviours Workforce development: from global to European higher education programs 10:00 to 19:20 Digital kiosks Olatz López Fernándeze-posterADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning 10:00 to 19:20 Digital kiosks Romain Bache-posterAdherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine 10:00 to 19:20 Digital kiosks Michael Froste-posterAdvancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan 10:00 to 19:20 Digital kiosks Paula Pinto Oliveirae-posterAdverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors 10:00 to 19:20 Digital kiosks Teodomiro Pirese-posterAgeing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users 10:00 to 19:20 Digital kiosks Lara Queiroz Sampaioe-posterAlcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis 10:00 to 19:20 Digital kiosks Lauren Halsalle-posterAlcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention 10:00 to 19:20 Digital kiosks Celestino Cunhae-posterAlcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding. 10:00 to 19:20 Digital kiosks Peter Nelsone-posterAn audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland 10:00 to 19:20 Digital kiosks Aidan Cooneye-posterAn evaluation of “harm reduction” outreach service evaluative research in Macau 10:00 to 19:20 Digital kiosks Augusto Nogueirae-posterAnabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder 10:00 to 19:20 Digital kiosks Raphael Magnolinie-posterAnalysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon 10:00 to 19:20 Digital kiosks Adriana Almeidae-posterAnxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents 10:00 to 19:20 Digital kiosks Jaroslava Sucháe-posterApplied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers 10:00 to 19:20 Digital kiosks Sofia Hemragee-posterApplying foresight research for drug policy: Lessons from the DRUG-PREP project 10:00 to 19:20 Digital kiosks Bert Hauspiee-posterAre Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study 10:00 to 19:20 Digital kiosks Said Boujrafe-posterAssessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project 10:00 to 19:20 Digital kiosks Omid Dadrase-posterAssessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study 10:00 to 19:20 Digital kiosks Laura Väätäinene-posterAssessing progress towards viral hepatitis B and C elimination in prison settings in the European region 10:00 to 19:20 Digital kiosks Riccardo Pisettae-posterAssessing the prevalence of problem gambling among the Slovenian population 10:00 to 19:20 Digital kiosks Špela Selake-posterAssessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes 10:00 to 19:20 Digital kiosks Siobhan Morsee-posterAssociation between slot machine gambling and debt recovery process-Finnish population-based study with register linkage 10:00 to 19:20 Digital kiosks Tiina Latvalae-posterBalancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment 10:00 to 19:20 Digital kiosks Andrea Johansson Capusane-posterBarriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany 10:00 to 19:20 Digital kiosks Ebtesam Salehe-posterBenefits of a Yoga intervention in portuguese female inmates: preliminary results 10:00 to 19:20 Digital kiosks Andreia Nisae-posterBuilding Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada 10:00 to 19:20 Digital kiosks Barbara Fornsslere-posterBuprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review 10:00 to 19:20 Digital kiosks Abhishek Guptae-posterBurden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns 10:00 to 19:20 Digital kiosks Vera Pinheiroe-posterBurnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study 10:00 to 19:20 Digital kiosks Cátia Coutinhoe-posterCan we prevent the misuse of prescription stimulants? : a case report 10:00 to 19:20 Digital kiosks Ivana Todorić Laidlawe-posterCannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data 10:00 to 19:20 Digital kiosks Lydia Johnson-Fergusone-posterCannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021 10:00 to 19:20 Digital kiosks Tamari Mgebrishvilie-posterCannabis use and withdrawal and escalation to psychiatric intensive care 10:00 to 19:20 Digital kiosks Edward Chesneye-posterCaring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals 10:00 to 19:20 Digital kiosks Brenda Sousa da Silvae-posterCase Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome 10:00 to 19:20 Digital kiosks Sofia Golbreiche-posterCatalysts for Change: Youth-Driven Insights in Opioid Harm Reduction 10:00 to 19:20 Digital kiosks Rebeca Calzadae-posterChallenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square 10:00 to 19:20 Digital kiosks Daniel Deimele-posterChallenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece. 10:00 to 19:20 Digital kiosks Apostolia Fragkoulie-posterChanges in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic. 10:00 to 19:20 Digital kiosks J. Maphisa Maphisae-posterCharacterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine 10:00 to 19:20 Digital kiosks MJ Stowee-posterChemsex: An Umbrella Review 10:00 to 19:20 Digital kiosks Liam Johnstonee-posterCombination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study 10:00 to 19:20 Digital kiosks Mance Buttrame-posterCommon mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation 10:00 to 19:20 Digital kiosks Faridah Nakomae-posterCommunity led networking and advocacy for the elimination of discrimination of women who use drugs in Europe 10:00 to 19:20 Digital kiosks Ligia Parodie-posterComorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania. 10:00 to 19:20 Digital kiosks Dorothy Mushie-posterCOMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY) 10:00 to 19:20 Digital kiosks Alice Deschenaue-posterComparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents 10:00 to 19:20 Digital kiosks Zanina Perevska e-posterComplicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit 10:00 to 19:20 Digital kiosks Ines Pereirae-posterComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors 10:00 to 19:20 Digital kiosks Carla Matiase-posterConceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry 10:00 to 19:20 Digital kiosks Carl Erik Fishere-posterContribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya. 10:00 to 19:20 Digital kiosks Esther Mumoe-posterCortical thickness and brain aging in individuals engaging in unhealthy alcohol use 10:00 to 19:20 Digital kiosks Marco Hermesdorfe-posterCOVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour 10:00 to 19:20 Digital kiosks Tina Peraicae-posterCrack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe. 10:00 to 19:20 Digital kiosks Luca Censie-posterCritical assessment of the role of compulsory treatment of drug use disorders in Germany 10:00 to 19:20 Digital kiosks Ingo Ilja Michelse-posterDCR in Paris : a constant experiment 10:00 to 19:20 Digital kiosks Victor Detreze-posterDegree of smartphone addiction in the university environment 10:00 to 19:20 Digital kiosks Raul Vernete-posterDeveloping a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa 10:00 to 19:20 Digital kiosks Julie-Anne Mac Donnelle-posterDeveloping practical tools for identifying and supporting treatment-relevant cognitive dys/functions 10:00 to 19:20 Digital kiosks Maria Bravo Aguilerae-posterDevelopment of complementary information to drug-related deaths statistics in Slovenia 10:00 to 19:20 Digital kiosks Mateja Jandle-posterDoping Prevention among Recreational Athletes and the Role of the Police 10:00 to 19:20 Digital kiosks Tobias Elgáne-posterDrug checking via Syringe Vending Machines 10:00 to 19:20 Digital kiosks Mariam Sheroziae-posterDrug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring. 10:00 to 19:20 Digital kiosks María Flores Lópeze-posterDrug-Related Deaths following Bariatric surgery: Case Series Report 10:00 to 19:20 Digital kiosks Eman Msharie-posterDUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users 10:00 to 19:20 Digital kiosks Richard Alecsander Reicherte-posterEffectiveness of the brief intervention for methamphetamine users in Poland 10:00 to 19:20 Digital kiosks Magdalena Rowickae-posterEffects of a universal school based alcohol prevention intervention 10:00 to 19:20 Digital kiosks Bert Hauspiee-posterEffects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study 10:00 to 19:20 Digital kiosks Jiecheng Rene-posterEfficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial 10:00 to 19:20 Digital kiosks Emmanuel Lahaiee-posterElectroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation 10:00 to 19:20 Digital kiosks Shelan Oforie-posterElectronic cigarettes use among secondary school students in Slovenia 10:00 to 19:20 Digital kiosks Helena Koprivnikare-posterEmpowering higher education teachers using tripartite drug awareness training model to support youth well-being 10:00 to 19:20 Digital kiosks Munir Sewanie-posterEnhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder 10:00 to 19:20 Digital kiosks Michael Smolkae-posterEnhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia 10:00 to 19:20 Digital kiosks Irma Kirtadzee-posterEnrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece 10:00 to 19:20 Digital kiosks Sotiris Lainase-posterEstimation of prevalence (and patterns) of cannabis use from various data sources 10:00 to 19:20 Digital kiosks Darja Lavtare-posterEthical considerations of responsible gambling in metaverse 10:00 to 19:20 Digital kiosks Susanne Uusitaloe-posterEvaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets 10:00 to 19:20 Digital kiosks Stephanie Hutchingse-posterEvaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB) 10:00 to 19:20 Digital kiosks Stuart Fishere-posterEvaluation of participants' experiences enrolled in a community-based mobile withdrawal management service 10:00 to 19:20 Digital kiosks Andrew Lodgee-posterExperiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment 10:00 to 19:20 Digital kiosks Julie Schampe-posterExperiences with Xylazine among Residential Treatment Patients 10:00 to 19:20 Digital kiosks Courtney Nordecke-posterExploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery 10:00 to 19:20 Digital kiosks Shinasa Shahide-posterExploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview. 10:00 to 19:20 Digital kiosks Nicola Worcmane-posterExploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway 10:00 to 19:20 Digital kiosks Svetlana Skurtveite-posterExploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services. 10:00 to 19:20 Digital kiosks Victoria Beeree-posterExploring the role of gender on treatment outcomes in older adults with alcohol use disorder 10:00 to 19:20 Digital kiosks Jeppe Tryggedssone-posterFeatures and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study 10:00 to 19:20 Digital kiosks Caitlin McClure-Thomase-posterFentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions 10:00 to 19:20 Digital kiosks Ewelina Silecka-Mareke-posterForgotten children - losses of children growing up with addicted parents 10:00 to 19:20 Digital kiosks Szilvia Kassaie-posterFraming alcohol policies in non-prohibitionist States: An existentialist dilemma? 10:00 to 19:20 Digital kiosks Subrata Biswase-posterFrequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine 10:00 to 19:20 Digital kiosks Natasha Simonovskae-posterFrom intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study 10:00 to 19:20 Digital kiosks Amelie Zachere-posterGender violence experienced by women who use drugs 10:00 to 19:20 Digital kiosks Ana Isabel Ibar-Fañanáse-posterGenerative AI to support Harm Reduction 10:00 to 19:20 Digital kiosks Angus Bancrofte-posterGlobal trends and Challenges of the Drug Phenomenon in Central Asia 10:00 to 19:20 Digital kiosks Ernest Robelloe-posterGratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder 10:00 to 19:20 Digital kiosks Charlotta Svenssone-posterHarm Reduction: A Pathway To Community Health in Nigeria 10:00 to 19:20 Digital kiosks Fatima Abiola Popoolae-posterHCV screening in the treatment centers for people with addictions: lessons learned 10:00 to 19:20 Digital kiosks Federica Mathise-posterHepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015 10:00 to 19:20 Digital kiosks Unai Perez de San Roman Landae-posterHigh and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history 10:00 to 19:20 Digital kiosks Andrea Anastasie-posterHIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes 10:00 to 19:20 Digital kiosks Martin Kåberge-posterHospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis 10:00 to 19:20 Digital kiosks Joana Silvae-posterHybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024) 10:00 to 19:20 Digital kiosks Marion Fale-posterIdentification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care 10:00 to 19:20 Digital kiosks Jennie Sundbyee-posterIf you don't know where you're going, why insist on running - A reflection on the lack of data on dropout... 10:00 to 19:20 Digital kiosks Sofia Freitase-posterImage and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results 10:00 to 19:20 Digital kiosks Julijana Zucchiati Godinae-posterImpact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto 10:00 to 19:20 Digital kiosks Isabel Pontee-posterImpact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis 10:00 to 19:20 Digital kiosks Maria Teresa Ponse-posterImpact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy 10:00 to 19:20 Digital kiosks Elaheh Javadi Arjmande-posterImpact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia 10:00 to 19:20 Digital kiosks Cayley Russelle-posterImplementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations. 10:00 to 19:20 Digital kiosks Sheimah El Beijjaji Bouzbitae-posterImplementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results 10:00 to 19:20 Digital kiosks Alba Abanadese-posterImproving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing. 10:00 to 19:20 Digital kiosks Teodora Ciolompeae-posterIn search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region 10:00 to 19:20 Digital kiosks Rui Tinocoe-posterIN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES 10:00 to 19:20 Digital kiosks Mariana Carvalhoe-posterInpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs 10:00 to 19:20 Digital kiosks Osunwale Onie-posterIntegrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions. 10:00 to 19:20 Digital kiosks Daniel Merciecae-posterIntervention methods for the psychological problems faced by the wives of individuals with substance use disorders. 10:00 to 19:20 Digital kiosks Ranasinghe Mudiyanselage Sanjeewani Senevirathnee-posterInvestigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem 10:00 to 19:20 Digital kiosks Fatmatüz Zehra Pehlivane-posterInvestigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan 10:00 to 19:20 Digital kiosks Jawwad Muhammad Shujaate-posterIs addiction a brain-disease? An overview of the evidence 10:00 to 19:20 Digital kiosks Chrysanthi Blithikiotie-posterIs Decriminalising drugs enough? Navigating alternatives to prohibitionism 10:00 to 19:20 Digital kiosks Jorge Quintase-posterIs Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible? 10:00 to 19:20 Digital kiosks Pamela Jacobsene-posterItalian teenagers’ perceived exposure to Digital Alcohol Marketing 10:00 to 19:20 Digital kiosks Franca Beccariae-posterItalian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder 10:00 to 19:20 Digital kiosks Teo Vignolie-posterLeveraging AI to supercharge the training and support of extended workforce in addiction services 10:00 to 19:20 Digital kiosks Christina Todorovae-posterLGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews 10:00 to 19:20 Digital kiosks Anne-Marie Augere-posterLife Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene 10:00 to 19:20 Digital kiosks Arash Setoodehe-posterLived/Living experiences: the potential for integrative collaborations 10:00 to 19:20 Digital kiosks Mary Beth Zenie-posterLong-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention 10:00 to 19:20 Digital kiosks Johanna Gripenberge-posterLong-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System 10:00 to 19:20 Digital kiosks Tove Sohlberge-posterLove Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style 10:00 to 19:20 Digital kiosks Jessica Dineene-posterMaking Hep C treatment more accessible for addictions patients in Belfast 10:00 to 19:20 Digital kiosks Andrew Teeneye-posterMania a Potu: Review of the literature 10:00 to 19:20 Digital kiosks Ines Valadae-posterMapping drug users’ spaces of fear in Cologne, Germany 10:00 to 19:20 Digital kiosks Bo Tackenberge-posterMapping psychedelic retreats and other practices in the EU 10:00 to 19:20 Digital kiosks Tereza Černíkováe-posterMeaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations 10:00 to 19:20 Digital kiosks Marcel Näthere-posterMedicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA) 10:00 to 19:20 Digital kiosks Lisa Stradae-posterMortality among long-term prescription opioid users 10:00 to 19:20 Digital kiosks Gabriela Rolováe-posterMortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis 10:00 to 19:20 Digital kiosks Pihla Sassie-posterNavigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study 10:00 to 19:20 Digital kiosks Patricia Dürlere-posterNegative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder 10:00 to 19:20 Digital kiosks Marina Cosenzae-posterNeurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence 10:00 to 19:20 Digital kiosks Elena Psederskae-posterNew criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project) 10:00 to 19:20 Digital kiosks Apostolos Tsirgoulase-posterNightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use 10:00 to 19:20 Digital kiosks Inês Miguel Rodrigues Armelime-posterNo alcohol at night – Polish experiences 10:00 to 19:20 Digital kiosks Marta Zin-Sedeke-posterOffspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study 10:00 to 19:20 Digital kiosks Fran Calvoe-posterOniomania: a case study according to the differential diagnosis 10:00 to 19:20 Digital kiosks Sofia Nunese-posterOniomania: what is known today? 10:00 to 19:20 Digital kiosks Margarida Duartee-posterOnline gambling and betting in India and their adverse psychological and social complications: A comprehensive review 10:00 to 19:20 Digital kiosks Shyam Sundar Kanagarajane-posterOnline gambling and Loneliness: A State of Knowledge. 10:00 to 19:20 Digital kiosks Volanirina Rasolofomamonjye-posterOpiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities 10:00 to 19:20 Digital kiosks Annika Gibbonse-posterOptimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland 10:00 to 19:20 Digital kiosks Lisa Schöline-posterOUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies 10:00 to 19:20 Digital kiosks Ulrike Möntmanne-posterPackaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis 10:00 to 19:20 Digital kiosks Matilda Nottagee-posterPeople with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance. 10:00 to 19:20 Digital kiosks Joanna Rajewska de Mezere-posterPersonality traits and recovery 10:00 to 19:20 Digital kiosks Elise Constance Fodstade-posterPilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study 10:00 to 19:20 Digital kiosks Jake Samorae-posterPiloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services 10:00 to 19:20 Digital kiosks Carla Filipa Bruguerae-posterPortuguese gym-goers versus Performance-enhancing Substances: What do we know? 10:00 to 19:20 Digital kiosks Ana Sofia Tavarese-posterPost-prison support for First Nations men in Australia and Canada 10:00 to 19:20 Digital kiosks Michael Doylee-posterPrevalence of BBD among PWID in treatment settings in Palestine between 2019-2023 10:00 to 19:20 Digital kiosks Abeer Habashe-posterPrevalence of substance use in Austrian prison systems 10:00 to 19:20 Digital kiosks Andrea Gampere-posterPrevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030) 10:00 to 19:20 Digital kiosks Mateja Markle-posterPrevention of FASD in Luxembourg – a status report 10:00 to 19:20 Digital kiosks Jonathan Useldinge-posterProblematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks 10:00 to 19:20 Digital kiosks Lichang Yaoe-posterProcess indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic 10:00 to 19:20 Digital kiosks Oscar M. Lozanoe-posterProfessional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies 10:00 to 19:20 Digital kiosks Rita Valinhoe-posterProgram evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre 10:00 to 19:20 Digital kiosks Andrew Lodgee-posterProviding psychiatric services for hepatitis C virus patients with substance use disorders 10:00 to 19:20 Digital kiosks Anna Gorodetskye-posterPsilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4 10:00 to 19:20 Digital kiosks Andreia Machado Brito-da-Costae-posterPsychological Phenotypes in Glambling Disorder: A case study using the Pathway Model 10:00 to 19:20 Digital kiosks Ana Llorentee-posterPsychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling 10:00 to 19:20 Digital kiosks Anu Sirolae-posterPsychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms 10:00 to 19:20 Digital kiosks Fermin Fernández Calderóne-posterPsychosocial Factors Affecting Drug Relapse Among Youth in Pakistan 10:00 to 19:20 Digital kiosks Abdul Waheed Tabishe-posterPublic Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group 10:00 to 19:20 Digital kiosks Paula Pinto Oliveirae-posterRecreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study 10:00 to 19:20 Digital kiosks Roni Deli-Housseine-posterRecreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing 10:00 to 19:20 Digital kiosks Lukas Eggenbergere-posterReitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia 10:00 to 19:20 Digital kiosks Pavla Chomynovae-posterResilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression 10:00 to 19:20 Digital kiosks Qi Daie-posterResults of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan 10:00 to 19:20 Digital kiosks Gunash Jafarovae-posterRhabdomyolysis in patients following opioid overdose 10:00 to 19:20 Digital kiosks Aleksandra Babulovskae-posterRiscos & Desafios Program: the students’ voice 10:00 to 19:20 Digital kiosks Gizela Rendoe-posterRisk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial 10:00 to 19:20 Digital kiosks Arild Opheime-posterRisks and challenges of scaling up the intervention – an analysis of the program dissemination process 10:00 to 19:20 Digital kiosks Carla Rochae-posterRisky online behavior in relation to social support, depression and anxiety in Czech adolescents 10:00 to 19:20 Digital kiosks Terezie Babilonováe-posterRole of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction 10:00 to 19:20 Digital kiosks Aleš Zajce-posterSCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON 10:00 to 19:20 Digital kiosks Ana Catarina Nunes da Silvae-posterSCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals 10:00 to 19:20 Digital kiosks Ana Pegoe-posterScottish stakeholder views on closing the evidence to practice gap in substance use prevention 10:00 to 19:20 Digital kiosks Tara Shivajie-posterSelf-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal 10:00 to 19:20 Digital kiosks Dipesh Bhattaraie-posterSelf-rated health among patients in opioid agonist therapy 10:00 to 19:20 Digital kiosks Jan Tore Daltveite-posterSleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective. 10:00 to 19:20 Digital kiosks Ana Llorentee-posterSmartphone addiction and sexual distress: preliminary findings of a study in Portugal 10:00 to 19:20 Digital kiosks Pedro Campose-posterSmoking among people who use drugs 10:00 to 19:20 Digital kiosks Ingeborg Lunde-posterSocial work diagnosis and intervention in a harm reduction service for People Who Use Drugs 10:00 to 19:20 Digital kiosks Teresa Castroe-posterSpanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance 10:00 to 19:20 Digital kiosks Conchita Sisi Martine-posterStigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes. 10:00 to 19:20 Digital kiosks Ashlyn Schwartze-posterStigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes 10:00 to 19:20 Digital kiosks Theresa Caruanae-posterSubstance Use Among College Students in India: Necessity for Intervention 10:00 to 19:20 Digital kiosks Anju Dhawane-posterSubstance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced 10:00 to 19:20 Digital kiosks Mayar Nawarae-posterSuicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review 10:00 to 19:20 Digital kiosks Marco Mota Oliveirae-posterSystematic analysis of Interventions for Opioid Use Disorder Among Adolescents 10:00 to 19:20 Digital kiosks Joye Anestise-posterSystematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder 10:00 to 19:20 Digital kiosks Anna Powelle-posterSystemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment 10:00 to 19:20 Digital kiosks Joëlle Maguire-Le-posterTell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers 10:00 to 19:20 Digital kiosks João Fariae-posterThe addiction nursing workforce empowerment - from international perspective to the national implementation and bac 10:00 to 19:20 Digital kiosks Vendula Pokornáe-posterThe association between alexithymia and binge drinking among young people 10:00 to 19:20 Digital kiosks Pelin Alpaye-posterThe association between psychological distress and alcohol consumption and physical activity 10:00 to 19:20 Digital kiosks Silvia Eiken Alperse-posterThe Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment 10:00 to 19:20 Digital kiosks Marc Auriacombee-posterThe comparison and analysis of blood antioxidant levels in alcohol and drug addiction 10:00 to 19:20 Digital kiosks Nelly Sapojnikovae-posterThe Development of an Alcohol Strategy for the Northwest Territories, Canada 10:00 to 19:20 Digital kiosks Bryany Denninge-posterThe effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT 10:00 to 19:20 Digital kiosks Parnian Rafeie-posterThe effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review 10:00 to 19:20 Digital kiosks Annika Theodouloue-posterThe effects of syringe service programs on overdose deaths in Tennessee 10:00 to 19:20 Digital kiosks Ryan Edgertone-posterThe Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review 10:00 to 19:20 Digital kiosks Manuel Jesús Ruiz Muñoze-posterThe impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances 10:00 to 19:20 Digital kiosks Filipe Pintoe-posterThe Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022 10:00 to 19:20 Digital kiosks Loren Kocke-posterThe Last Decade in Turkish Addiction Research: A Thesis-Based Analysis 10:00 to 19:20 Digital kiosks Belgin Varole-posterThe lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use 10:00 to 19:20 Digital kiosks Alexandros Tifase-posterThe Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong 10:00 to 19:20 Digital kiosks Katie Lowee-posterThe necessary adaptation of a public Therapeutic Community to new needs of the treatment process. 10:00 to 19:20 Digital kiosks Rita Fazenda Vieirae-posterThe potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies 10:00 to 19:20 Digital kiosks André Almeidae-posterThe prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis 10:00 to 19:20 Digital kiosks Danielle Dawsone-posterThe prevalence of Mental Health Disorders Among Cannabis Users 10:00 to 19:20 Digital kiosks Ada Hočevar Grome-posterThe prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use. 10:00 to 19:20 Digital kiosks Catherine Comiskeye-posterThe recovery of people with addictive behaviours and dependencies: intervention strategies of social workers 10:00 to 19:20 Digital kiosks Sara Carvalhoe-posterThe role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use 10:00 to 19:20 Digital kiosks Linda Kočvarováe-posterThe role of coping in the association between cannabis use disorder and mental health; a one-year prospective study 10:00 to 19:20 Digital kiosks Nora de Bodee-posterThe role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients 10:00 to 19:20 Digital kiosks Lea Kozinae-posterThe role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use 10:00 to 19:20 Digital kiosks Simon Ghinassie-posterThe role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders 10:00 to 19:20 Digital kiosks Els Santense-posterTHE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION 10:00 to 19:20 Digital kiosks Farshad moshirie-posterThe Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester 10:00 to 19:20 Digital kiosks Nikolaos Mylonase-posterTherapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief. 10:00 to 19:20 Digital kiosks Mafalda Pinto Ribeiroe-posterTherapy of alcohol-dependent women serving prison sentences in Polish prisons 10:00 to 19:20 Digital kiosks Hanna Karaszewskae-posterThreat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use 10:00 to 19:20 Digital kiosks Jasmin Lostedte-posterTraining Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study 10:00 to 19:20 Digital kiosks Paulo Seabrae-posterTransgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study 10:00 to 19:20 Digital kiosks Dean Connollye-posterTREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE 10:00 to 19:20 Digital kiosks Andrej Kastelice-posterTrilhos - Evaluation of a developmental prevention program 10:00 to 19:20 Digital kiosks Inês Abraãoe-posterTrust in healthcare providers for information about cannabis 10:00 to 19:20 Digital kiosks Meredith Meachame-posterTwenty years of integrated treatment of dual disorders in the netherlands: lessons learned 10:00 to 19:20 Digital kiosks Anneke van Wamele-posterUnderstanding Overdose Risk Perception in People who use Drugs - A Systematic Review 10:00 to 19:20 Digital kiosks Kerry B.D. Campbelle-posterUnmasking addictions: exploring the role of attributional styles 10:00 to 19:20 Digital kiosks Ana Tavarese-posterUse of CBD and low-THC products in North Macedonia 10:00 to 19:20 Digital kiosks Sanja Proshevae-posterUsing a digital client segmentation tool among clients with problematic substance use 10:00 to 19:20 Digital kiosks Ella Plaamie-posterUsing Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns 10:00 to 19:20 Digital kiosks Rebecca Kuipere-posterVeterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply 10:00 to 19:20 Digital kiosks Barry Logane-posterVoices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views 10:00 to 19:20 Digital kiosks Laura Browne-posterWhen substance use disorder and eating disorder intersect: an integrated care tool. 10:00 to 19:20 Digital kiosks Zoya Barbiere-posterWillingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm 10:00 to 19:20 Digital kiosks Elin Holméne-posterWorkforce development and co production as key enablers of successful service delivery. 10:00 to 19:20 Digital kiosks Martin Blakebroughe-posterWorking memory in context: the role of alcohol distractors in low to heavy alcohol drinkers 10:00 to 19:20 Digital kiosks Karis Colyer-Patele-posterWorking Towards Health and Wellness: The Infinite Pathways of Recovery 10:00 to 19:20 Digital kiosks Meghann Perrye-poster“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth 10:00 to 19:20 Digital kiosks Christian Barborini 11:50 DiscussionCannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research 11:50 to 13:20 Auditorium I Rosalie Liccardo PaculaSusan Weiss Hanan AbramoviciBeau KilmerFrançois GagnonShort communicationA systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery 11:50 to 13:20 Room 1.07 Louise McCullochOral presentationBipolar disorder and severe poisoning due to medicines or illicit substances 11:50 to 13:20 Auditorium VII Aleksi HaminaShort communicationEmbodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process 11:50 to 13:20 Room 1.07 Meghann PerryShort communicationEmotional dysregulation as a predictor of cocaine severity and withdrawal symptoms 11:50 to 13:20 Room 1.07 Alba Palazón-LlechaShort communicationExploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience 11:50 to 13:20 Room 1.07 Myriam BeaulieuOral presentationHazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study 11:50 to 13:20 Auditorium VII Miriam LorenzOral presentationModelling the wider socio-economic costs of problematic opioid use in the UK 11:50 to 13:20 Auditorium VIII George KeelOral presentationPrevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model 11:50 to 13:20 Auditorium VIII Hayley JonesShort communicationRecovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England. 11:50 to 13:20 Room 1.07 Emma-Joy HollandOral presentationSuicide-related service presentations following residential treatment for substance use disorders: a data linkage study 11:50 to 13:20 Auditorium VII Calvert TisdaleShort communicationThe effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders 11:50 to 13:20 Room 1.07 Eline Borger RognliOral presentationThe impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment 11:50 to 13:20 Auditorium VII Nicola JonesShort communicationThe role of specialist substance use and addiction treatment in building recovery capital 11:50 to 13:20 Room 1.07 Florian De MeyerOral presentationTwenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender 11:50 to 13:20 Auditorium VIII Amanda RoxburghOral presentationUnderestimate of deaths due to specific opioids in England and Wales for a decade 11:50 to 13:20 Auditorium VIII Shuoqi ChenShort communicationUnderstanding the process of drug addiction recovery through learning from lived experience 11:50 to 13:20 Room 1.07 Thomas Martinelli 14:20 Oral presentationWhy is a gender perspective needed in the drug field? Insight from the latest European drugs data. 14:20 to 15:50 Auditorium VIII Linda MontanariShort communicationAttention and reward related brain activity in cannabis users: A registered report of a longitudinal study 14:20 to 15:50 Auditorium III Inês MacedoOral presentationChanges in cannabis potency and cannabis-related harms: A 22-year ecological study in Denmark 14:20 to 15:50 Room 1.07 Kristine Rømer ThomsenShort communicationCognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders 14:20 to 15:50 Auditorium III Jens HetlandShort communicationDoes lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence? 14:20 to 15:50 Auditorium III Raimondo BrunoShort communicationEasy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use. 14:20 to 15:50 Auditorium III Nina AuestadOral presentationGender Compression Over Time in Measures of Cannabis Use by Age and Cohort in the United States 14:20 to 15:50 Auditorium VIII Michael VuoloOral presentationJudge Demographics and Their Impact on Sentencing of Drug Crimes 14:20 to 15:50 Auditorium IV Sarah Henry DavisOral presentationLeximetric analysis of drug laws and evaluation of outcomes: cross-country analyses approach 14:20 to 15:50 Auditorium IV Carla RossiOral presentationNavigating the Shift: Understanding the Dynamics of Cannabis Use in Germany Amidst Legalization Prospects 14:20 to 15:50 Auditorium IV Sally OlderbakShort communicationNeural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions 14:20 to 15:50 Auditorium III Marc RitterShort communicationNK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls 14:20 to 15:50 Auditorium III Lexi HandOral presentationPharmacology of generic ban-evading synthetic cannabinoid receptor agonists: are new compounds spicing up the market? 14:20 to 15:50 Room 1.07 Marie DeventerOral presentationSmoking and nicotine use behaviours among women of reproductive age: a ten-year population study in England 14:20 to 15:50 Auditorium VIII Sharon CoxShort communicationSocial Cognition in people with substance use disorders 14:20 to 15:50 Auditorium III Sónia RodriguesShort communicationThe bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception 14:20 to 15:50 Auditorium III Mateo Leganes-FonteneauOral presentationThe challenge of cannabis quantification: from theory to practice 14:20 to 15:50 Room 1.07 Cláudia Sousa-ReisOral presentationThe effects of legislative measures for 3-MMC in the Netherlands on drug sample composition and self-reported effects. 14:20 to 15:50 Auditorium IV Pieter OomenOral presentationThe perspective of transgender and non-binary people on their substance use trajectories and resilience processes 14:20 to 15:50 Auditorium VIII Abdelhakim Missoum 16:00 Short communicationAssociations between mental health and substance use in higher education students in Germany – a cross-sectional study 16:00 to 17:30 Room 1.08 Robert HrynyschynShort communicationBarriers and facilitators for accessing HCV care in PWID: a qualitative study using an intersectional approach 16:00 to 17:30 Room 1.08 Ilhame AnwarShort communicationBarriers and facilitators to accessing drug treatment services for people who use drugs in Oman: a qualitative study. 16:00 to 17:30 Room 1.08 Oral presentationConsidering the prevention workforce: a study on practitioner needs when recommending substance use interventions 16:00 to 17:30 Room 1.06 Natalie BlackburnOral presentationDocumenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia 16:00 to 17:30 Auditorium VI Kasun RathnayakeOral presentationDrug markets and financial flows: underground banking in the Netherlands 16:00 to 17:30 Auditorium VI Nienke LiebregtsOral presentationEffects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE) 16:00 to 17:30 Auditorium VI Lavinia BaltesShort communicationEnvisioning youth-dedicated overdose prevention and drug consumption sites in Canada and Portugal 16:00 to 17:30 Room 1.08 Kali-olt SedgemoreOral presentationEvaluating and comparing health quality for addiction treatment in the Lazio region, Italy 16:00 to 17:30 Room 1.06 Antonella CamposeragnaShort communicationExploring the biopsychosocial needs of ageing heroin users in treatment in Malta: implications for service provision 16:00 to 17:30 Room 1.08 Anna GrechOral presentationHow do purity and price of cocaine affect consumption in Austria? 16:00 to 17:30 Auditorium VI Birgit PriebeOral presentationHow do you make it work? A pragmatic framework for the Sustained Uptake of Service Innovations (SUSI). 16:00 to 17:30 Room 1.06 Catherine FoleyOral presentationInstruments assessing Gaming Disorder in children and adolescents – A systematic review of psychometric properties 16:00 to 17:30 Room 5B Samantha SchlossarekShort communicationLate relapse among ex-smokers using e-cigarettes following a quit attempt: a prospective one-year follow-up study 16:00 to 17:30 Room 1.08 Lion ShahabShort communicationMental health in people with hazardous cannabis and alcohol use - insights from a study of regulated cannabis sales 16:00 to 17:30 Room 1.08 Maximilian BuschnerOral presentationPlanning and Monitoring drug and alcohol treatment in Denmark. The MapPlan project. 16:00 to 17:30 Room 1.06 Mads Uffe PedersenOral presentationScreening Measures on Internet Use Disorders in Children and Adolescents - A Delphi Study 16:00 to 17:30 Room 5B Hans-Juergen RumpfShort communicationSubstance induced psychosis among persons with concurrent mental health and substance use disorders under pandemic 16:00 to 17:30 Room 1.08 Jørgen G. BramnessShort communicationSuicide by people in contact with drug and alcohol services: a national study 2021 to 2022 16:00 to 17:30 Room 1.08 Patrick HorganOral presentationThe Gaming Disorder Identification Test (GADIT) - A screening tool for Gaming Disorder based on ICD-11 16:00 to 17:30 Room 5B Gary ChanOral presentationThe Problematic Behaviour Scale (PBS-10): psychometric characteristics and cut-offs using Swiss national survey data 16:00 to 17:30 Room 5B Sebastian Mader 17:50 Oral presentationApplication of the International Standards for the Treatment of Drug Use Disorders and the Key Quality Standards for service appraisal 17:50 to 19:20 Auditorium II Anja BusseOral presentationInternational Consortium on Quality in Substance Use Disorders Treatment 17:50 to 19:20 Auditorium II Rita NotarandreaOral presentationInsights from the Recipient of the first ICQ Quality Seal Award 17:50 to 19:20 Auditorium II Michael W. JohnsonOral presentationPIQAT: Program for International Quality Assurance in Treatment 17:50 to 19:20 Auditorium II Mariano MontenegroOral presentation(De)criminalisation of drug possession as a litmus test of national drug policy? Experience from the Czech Republic 17:50 to 19:20 Auditorium VI Petr ZemanOral presentation20-year trends in Australian methamphetamine-related deaths: An age–period–cohort–interaction analysis 17:50 to 19:20 Auditorium IV Oisin StronachOral presentationA Collaborative Approach to New Drug Identification in an Emerging Drug Early Warning System 17:50 to 19:20 Auditorium III Donna PapsunShort communicationAdão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations 17:50 to 19:20 Room 1.05 Paulo AnjosShort communicationAre Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample 17:50 to 19:20 Room 1.05 Louisa PiccoOral presentationAssessing quality of substance use treatment in legal settings: lessons from United States drug courts 17:50 to 19:20 Auditorium VI Steven BelenkoShort communicationBeing Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway. 17:50 to 19:20 Room 1.06 Vegard HauklandOral presentationCodeine, oxycodone, and tramadol prescription prior to overdose deaths compared to toxicological findings 17:50 to 19:20 Auditorium IV Hilde EdvardsenShort communicationDeath after residential treatment for opioid use disorder among people using fentanyl 17:50 to 19:20 Room 1.06 Jan GryczynskiOral presentationEmergence of semi-synthetic cannabinoids in Europe – a perspective from the European Union Early Warning System 17:50 to 19:20 Auditorium III Rachel ChristieShort communicationGlobal utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder 17:50 to 19:20 Room 1.06 Michael FrostShort communicationHCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups 17:50 to 19:20 Room 1.05 Solange Mendes AscensãoShort communicationImproving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia. 17:50 to 19:20 Room 1.05 Elena Torrell -PedreiraOral presentationLaw Enforcement Encounters and Decriminalization Gaps: Insights from People Who Use Drugs in Oregon Post-Measure 110 17:50 to 19:20 Auditorium VI Morgan GodvinShort communicationLooking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales 17:50 to 19:20 Room 1.05 Michelle HughesOral presentationMedical use of psychedelic substances: EUDA's monitoring of key developments 17:50 to 19:20 Auditorium VIII Alexander SöderholmOral presentationMonitoring intravenous drugs use in Spain through syringe residue analysis 17:50 to 19:20 Auditorium IV Carlos Pernas-FraguelaShort communicationOxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021 17:50 to 19:20 Room 1.06 Eirik HaarrOral presentationPolice drug diversion in England and Wales: Findings from a realist process evaluation 17:50 to 19:20 Auditorium VI Alex Beerjeraz Short communicationPrevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care 17:50 to 19:20 Room 1.05 Eva-Carina HeierOral presentationQuantifying and expanding alternatives to arrest for use and possession offences for illicit drugs 17:50 to 19:20 Auditorium VI Caitlin HughesOral presentationSelf-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees. 17:50 to 19:20 Auditorium VIII Frederiek SchuttenShort communicationSTTBI risk reduction with OAT among people with prescription-type opioid use disorder 17:50 to 19:20 Room 1.05 M. Eugenia SociasOral presentationSynthetic cathinones in drug-related deaths – an alarming issue or triviality? 17:50 to 19:20 Auditorium III Ilkka OjanperäOral presentationThe U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights 17:50 to 19:20 Auditorium VIII Beau KilmerOral presentationTrends in GHB use and harms in Australia 17:50 to 19:20 Auditorium III Rachel SutherlandShort communicationTrends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020 17:50 to 19:20 Room 1.06 Gráinne CousinsOral presentationWhat are the reasons for injecting methadone? A qualitative study among people who inject drugs in Barcelona 17:50 to 19:20 Auditorium IV Gabriela Barbaglia Thu 24 Oct 11:50 Oral presentationLong-acting injectable buprenorphine for opioid use disorder: key findings from a longitudinal qualitative study 11:50 to 13:20 Auditorium IV Joanne Nealee-short communicationEnsuring Quality Care: community-led monitoring of client satisfaction and accessibility of OAT programs 11:50 to 13:20 Auditorium IV Maria PlotkoOral presentationAdapting Opioid Therapy: Transition from Methadone to Slow-Release Morphine Amid COVID-19 Supply Chain Disruptions 11:50 to 13:20 Auditorium IV Artūras BarkusOral presentationA Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids 11:50 to 13:20 Room 1.08 Evelyn HearneShort communicationA scoping review of mass media interventions intended to reduce stigma towards people who use drugs 11:50 to 13:20 Auditorium VII Adam HollandOral presentationA wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland 11:50 to 13:20 Room 5A Livia AndraniOral presentationCannabis policy and practice in Finland: from social media discussions to citizens initiatives 11:50 to 13:20 Room 1.08 Aleksi HupliShort communicationChanges in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022 11:50 to 13:20 Auditorium VII Kanna HayashiShort communicationDefinition of public amenity in drug consumption room literature: A scoping review 11:50 to 13:20 Auditorium VII Bianca WhitesideOral presentationDrugs and climate change: knowledge gaps in monitoring environmental impacts of drugs 11:50 to 13:20 Room 1.08 Tim SurmontShort communicationEnhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room 11:50 to 13:20 Auditorium VII Benjamin ScherOral presentationEuropean Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO 11:50 to 13:20 Room 5A Elisa ForneroOral presentationImpact of long-acting depot buprenorphine post-release from custody– Early findings from the Release Study 11:50 to 13:20 Auditorium IV Adrian DunlopOral presentationKey challenges for alcohol epidemiology and alcohol control policy evaluation 11:50 to 13:20 Auditorium VI Jürgen RehmOral presentationLegally grey? Drug checking perspectives in the CEECA region 11:50 to 13:20 Auditorium VI Eliza KurcevičShort communicationOverdoses in the drug consumption room in Oslo: route of administration matters! 11:50 to 13:20 Auditorium VII Desiree EideOral presentationPerceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids 11:50 to 13:20 Room 1.08 Melis SelamogluOral presentationPublic health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use. 11:50 to 13:20 Auditorium VI Sophie HendersonShort communicationReasons for (non-)using a drug consumption room: the point of view of drug users. 11:50 to 13:20 Auditorium VII Sanda SamitcaShort communicationSafe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England. 11:50 to 13:20 Auditorium VII Magdalena HarrisOral presentationSynthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets 11:50 to 13:20 Room 5A Pierre EsseivaOral presentationThe Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022 11:50 to 13:20 Auditorium VI Pam KentShort communicationThe Value of Peer Research: A Peer Perspective 11:50 to 13:20 Auditorium VII Christos AnastasiouOral presentationWhat can Portugal do to prevent be caught off guard again in the drug domain? 11:50 to 13:20 Room 5A Alcina Correia 14:20 Short communicationMaking a case for health promotion theoretically underpinned policies and practices around alcohol in workplace settings 14:20 to 15:50 Room 1.06 Lolita AlfredShort communicationIntroducing the European Prevention Curriculum (EUPC) in Austria – findings from a pilot implementation 14:20 to 15:50 Room 1.06 Martin BuschShort communicationAdvancing Science-Based Prevention: Insights from the EUPC Training in Bosnia and Herzegovina 14:20 to 15:50 Room 1.06 Amir HasanovicShort communicationPiloting EUPC Training in the Republic of Georgia: Lessons Learned 14:20 to 15:50 Room 1.06 Jana D. JavakhishviliShort communicationTRAINING ON THE EUROPEAN PREVENTION CURRICULUM (EUPC) FOR DOPs- THE CYPRIOT EXPERIENCE 14:20 to 15:50 Room 1.06 Maria MatheouShort communicationThe Frontine Politeia project: the need for involving prevention implementers within substance use and crime prevention 14:20 to 15:50 Room 1.06 Annemie CooneShort communicationStrengthening the capacity and agency of drug prevention stakeholders on the key issue of evidence-based prevention. 14:20 to 15:50 Room 1.06 Rachele DoniniShort communicationA multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial 14:20 to 15:50 Room 1.05 Suzanne NielsenShort communicationA socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic 14:20 to 15:50 Room 1.05 Katie McCormickShort communicationAn economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis 14:20 to 15:50 Room 1.05 Asier Narbarte ArzuagaOral presentationAssociations between opioid agonist therapy exposure and chronic pain characteristics among people who inject drugs 14:20 to 15:50 Auditorium IV Sasha UdhesisterShort communicationEffect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment 14:20 to 15:50 Room 1.05 Karl Trygve Druckrey-FiskaaenShort communicationEmpowering Global Drug Prevention: A Systematic Approach 14:20 to 15:50 Room 1.06 Ali YassineShort communicationHomeless people and mental health: an observational study in an Emergency Shelter in Lisbon 14:20 to 15:50 Room 1.05 Gonçalo HenriquesShort communicationMulti Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland 14:20 to 15:50 Room 1.05 Andreas MarkoulidakisShort communicationTreatment pathways and transitions of young adults during opioid maintenance treatment 14:20 to 15:50 Room 1.05 Sanna Iivonen 16:00 Oral presentationExperiences of building a Prompt Response Network for emerging drugs of concern in Australia 16:00 to 17:30 Room 1.05 Brendan CliffordOral presentationEmerging Drug trends in Japan: rethinking prevention strategies 16:00 to 17:30 Room 1.05 Hironobu FujiwaraOral presentationExploring Novel Psychoactive Substances Among Kazakhstan's Youth: A Focus on Emerging Trends and Risks 16:00 to 17:30 Room 1.05 Mariya PrilutskayaOral presentationThe case of Kratom: from traditional medical to recreational use 16:00 to 17:30 Room 1.05 Vicknasingam Balasingam Oral presentation25 years of monitoring the Dutch cannabis market using chemical analys: trends, developments and technical discussion 16:00 to 17:30 Room 1.08 Pieter OomenOral presentationA national program to scale-up decentralized HCV point-of-care testing and treatment in Australia 16:00 to 17:30 Auditorium IV Jason GrebelyOral presentationBrorphine analogues as new psychoactive substances: in vitro and in vivo pharmacological characterization 16:00 to 17:30 Auditorium III Marthe VandeputteOral presentationDropout from addiction treatment: predictors, patient profiles, outcomes, and recommendations to improve care. 16:00 to 17:30 Auditorium VII Marie-Josee FleuryOral presentationDrug monitoring by samples seized at 2018, 2022 and 2023 BOOM festival editions 16:00 to 17:30 Room 1.08 Carla Filipa FerreiraOral presentationHCV Community-led monitoring: from consultation to effective policy contributions 16:00 to 17:30 Auditorium IV Lynn JefferysJoana CanedoOral presentationIn vitro cannabinoid activity-based screening of seized plant materials: a future-proof harm reduction strategy? 16:00 to 17:30 Auditorium III Axelle TimmermamnOral presentationLECUCA: Analysis of Brazil's largest open drug scene using time-series cross-sectional survey data 16:00 to 17:30 Room 1.08 Clarice MadrugaOral presentationModelling the impact of scaling up of HCV case finding and treatment for people who inject drugs in England 16:00 to 17:30 Auditorium IV Zoe WardOral presentationNeurotoxicity of synthetic cathinones: Can metabolism play a role? 16:00 to 17:30 Auditorium III Alexandra AntunesOral presentationPharmacology of 30 semisynthetic cannabinoids – and why details matter when assessing the harm potential of seized drugs 16:00 to 17:30 Auditorium III Christophe StoveOral presentationPilot HCV Birth Cohort Screening in UK Primary Care using a postal oral fluid home testing kit: the HEPCAPP StudyPP STUDY 16:00 to 17:30 Auditorium IV Matt HickmanOral presentationService user and Carer perspective on Treatment for Co-Occurring Mental Health and Substance Use Problems (RECO Study) 16:00 to 17:30 Auditorium VII Elizabeth HughesOral presentationThe use of patient-reported outcomes in residential alcohol & drug services in Belgium: findings from the OMER-BE study 16:00 to 17:30 Auditorium VII Amine ZerroukOral presentationTrends in illicit and licit substance use across Spain – A comprehensive three-year wastewater-based epidemiology study. 16:00 to 17:30 Room 1.08 José Benito Quintana 17:50 Oral presentationEpidemiology of injecting drug use and injection related harms among people who are incarcerated 17:50 to 19:20 Auditorium IV Louisa DegenhardtShort communicationA comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study 17:50 to 19:20 Room 1.06 Nadine HeckelOral presentationAcute drug-toxicity presentations involving polydrug use to Euro-DEN Plus sentinel hospitals in Europe from 2014 to 2022 17:50 to 19:20 Room 5B Peter HeudtlassOral presentationContext specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK 17:50 to 19:20 Auditorium IV Peter McCullochOral presentationData collection on acute drug toxicity using the Euro-DEN plus model in countries bordering the European Union 17:50 to 19:20 Room 5B Thomas NéfauOral presentationInpatient admissions in people with opioid dependence: a portuguese population-based observational retrospective study 17:50 to 19:20 Room 5B José Miguel PaupérioOral presentationIt is time to take nitrous oxide seriously 17:50 to 19:20 Room 5C Julaine AllanShort communicationManaging the drug-driver: insights from Victoria’s large-scale roadside testing program 17:50 to 19:20 Room 1.06 Michael FitzharrisShort communicationMetabolite profile of synthetic cannabinoids seized in Portugal 17:50 to 19:20 Room 1.06 Rita Padinha LopesOral presentationNangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants 17:50 to 19:20 Room 5C Jodie GriggOral presentationNew challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg 17:50 to 19:20 Room 5C Marcus MartensOral presentationNon-Fatal Overdose: A Decade-Long Analysis of Inner-City Hospitals and Nationwide Trends Across Ireland (2011-2021) 17:50 to 19:20 Room 5B Jo-Hanna IversOral presentationPopulation aging and apparent decline in initiation of injecting drug use in Australia 17:50 to 19:20 Room 5C Olivia PriceShort communicationProject on fine default prisoners with substance abuse problems – preliminary findings of an evaluation and impact study 17:50 to 19:20 Room 1.06 Jukka LeinonenShort communicationRecommendations from the government cannabis committee on the legal availability of vaping products. 17:50 to 19:20 Room 1.06 Robert PerreaultOral presentationThe development of a toolkit to support the elimination of viral hepatitis B and C in prisons 17:50 to 19:20 Auditorium IV Erika DuffellShort communicationThe experience of aging among patients in opioid assisted treatment. A qualitative study. 17:50 to 19:20 Room 1.06 Siv-Elin Leirvåg CarlsenShort communicationThe impact of Cannabis market Regulation on adolescents in Uruguay 17:50 to 19:20 Room 1.06 Leticia KeuroglianOral presentationTowards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023 17:50 to 19:20 Auditorium IV Eirik Opheim Fri 25 Oct 11:50 Oral presentationEffectiveness of Machine Learning Based Adjustments to an eHealth Intervention Targeting at Risk Alcohol Use 11:50 to 13:20 Auditorium II Matthijs BlankersOral presentationIdentification and treatment of AUD with the 15-method – Evaluating effectiveness of the method in Danish primary care 11:50 to 13:20 Auditorium II Anette Søgaard NielsenOral presentationSmartphone-Delivered Cognitive Bias Modification for Reducing Harmful Drinking amongst middle – older age adults 11:50 to 13:20 Auditorium II Victoria ManningOral presentationAdvancing Harm Reduction and Saving Lives: A Comprehensive Evaluation of Initiatives and Outcomes in Greece. 11:50 to 13:20 Room 5A Athanasios TheocharisShort communicationAn action plan for synthetic opioids - The Zurich approach 11:50 to 13:20 Room 1.05 Dominique SchoriOral presentationAn online survey of cannabis users and ex-users in Ireland 11:50 to 13:20 Room 5B Philip JamesShort communicationCommunity attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia 11:50 to 13:20 Room 1.05 Sara LiuShort communicationDevelopment of an evidence-based classification framework for psychoactive substances in the illicit drug market 11:50 to 13:20 Room 1.05 Michèle Boileau-FalardeauOral presentationDo Self-Report Drug Use Surveys Produce the Same Results in Print and Online Mode? Findings from a Dual Mode Survey. 11:50 to 13:20 Room 5B Stelios StylianouOral presentationDrug checking: a harm reduction intervention to address the illicit drug toxicity crisis in a Canadian setting 11:50 to 13:20 Room 5A Lianping TiOral presentationDrug use in French prisons. Results of the ESSPRI survey 11:50 to 13:20 Room 5C Caroline ProtaisShort communicationGabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology 11:50 to 13:20 Room 1.05 Gráinne CousinsShort communicationIncreasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS 11:50 to 13:20 Room 1.05 Gregorio PlanchueloShort communicationMDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands 11:50 to 13:20 Room 1.05 Lavinia StegemannOral presentationNeeds & Modalities of Drug checking for Drug Users: Perspective of People with Lived Experience and Service Providers. 11:50 to 13:20 Room 5A Jean-Sébastien FalluShort communicationNew research unit provides evidence to address national addictions policy challenges 11:50 to 13:20 Room 1.05 Leonie BroseOral presentationOnline approach and characteristics of the hidden population with substance use disorder that doesn’t reach treatment 11:50 to 13:20 Room 5B Ilias ParaskevopoulosOral presentationPrison-based treatment needs for people with a history of substance use disorder: A nationwide cohort study 11:50 to 13:20 Room 5C Birgitte ThylstrupOral presentationSubstance use and psychological states in imprisoned population in Greece—Key findings from a recent nationwide survey 11:50 to 13:20 Room 5C Ioulia BafiShort communicationThe emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward 11:50 to 13:20 Room 1.05 Nicki KilleenOral presentationWhat can we learn about poly-drug use among frequent cannabis users? results from the European Web Survey on Drugs 11:50 to 13:20 Room 5B Davide FortinOral presentationWhat you might do versus what you actually do: measuring participant drug behaviours in drug checking services 11:50 to 13:20 Room 5A Anna Olsen 14:20 Oral presentationUpdate on the situation in the Netherlands (tbc) 14:20 to 15:50 Auditorium VIII Margriet Van LaarOral presentationCannabis law reform in Switzerland: purpose, opportunities, and risks of local pilot projects 14:20 to 15:50 Auditorium VIII Frank ZobelOral presentationIssues of transport, driving safety & intoxication for opioid agonist treatment clients in New South Wales, Australia 14:20 to 15:50 Auditorium VI Daniel WinterOral presentationCannabis law reform in Germany: a rocky road to a partial legalisation 14:20 to 15:50 Auditorium VIII Jakob MantheyOral presentationPhysical conditions and associated health service utilization among individuals with substance-related disorders 14:20 to 15:50 Auditorium VI Christophe HuỳnhOral presentationCannabis law reform in Luxembourg: first observations after its change among recreational cannabis users and non-users 14:20 to 15:50 Auditorium VIII Nadine BerndtOral presentationThe effect of substance use disorders on vaccine uptake, acceptance, and adherence: a global systematic review 14:20 to 15:50 Auditorium VI Eva Maria HavelkaOral presentationOut of treatment drug and alcohol users in England: ‘Unmet Treatment Need’? 14:20 to 15:50 Auditorium VI Charlie LloydShort communicationAddressing the needs of individuals with concurrent disorders: a complexity arising 14:20 to 15:50 Room 1.05 karine GaudreaultShort communicationBreaking Chains: Interventions for Reducing Internalized Stigma and Boosting Self-Esteem in Substance Use Behaviors 14:20 to 15:50 Room 1.05 Andreia FloridoShort communicationFunctional recovery among patients with dual disorders: the role of stigma 14:20 to 15:50 Room 1.05 Nusa SegrecShort communicationIntervention variability predicts social rehabilitation indicators at discharge in long-term residential treatment. 14:20 to 15:50 Room 1.05 Katia BarretoOral presentationInterventions to reduce harms related to drug use among people who experience incarceration: A systematic review 14:20 to 15:50 Auditorium VII Christel MacdonaldShort communicationMitigating Trauma and Problematic Drug Use with a Focus on Empathy – Insights from Metzineres 14:20 to 15:50 Room 1.05 Aura Roig FortezaOral presentationPRS20: drug use and perceived mental health concerns among people living in prison in the Grand-Duchy of Luxembourg 14:20 to 15:50 Auditorium VII Tom KugenerOral presentationRadio theater-based prison artistic intervention: a mixed-method evaluation 14:20 to 15:50 Auditorium VII Isabel SilvaShort communicationTowards a better connection 14:20 to 15:50 Room 1.05 Chico TagubaShort communicationTrauma-Informed care approach with people who use drugs 14:20 to 15:50 Room 1.05 Joana Pires